T. Rowe Price Investment Management
BHVN icon

T. Rowe Price Investment Management’s Biohaven BHVN Stock Holding History

T. Rowe Price Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-311
Closed -$5K – 894
2025
Q2 		$5K Sell
311
-643,635
-100% -$11.5M ﹤0.01% 682
2025
Q1 		$15.5M Buy
+643,946
New +$22.7M 0.01% 542
2024
Q2 		– Sell
-1,234,152
Closed -$67.5M – 626
2024
Q1 		$67.5M Buy
+1,234,152
New +$61.1M 0.04% 349

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management's BHVN Position: Q3 2025 in Review

T. Rowe Price Investment Management sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 311 shares — an estimated $5K sold.

T. Rowe Price Investment Management first reported a position in BHVN in Q1 2024 and held it in 3 quarters. The position peaked at $67.5M in Q1 2024. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • T. Rowe Price Investment Management reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 311 Biohaven shares in Q3 2025, an estimated $5K.
  • T. Rowe Price Investment Management first reported a position in Biohaven in Q1 2024 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Biohaven position peaked at $67.5M in Q1 2024.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.